cognitive cybersecurity intelligence

News and Analysis

Search

How Automation is Advancing Biosimilar Adoption

How Automation is Advancing Biosimilar Adoption

Many Americans are struggling with the high costs of biologic medications. Although biosimilars, which are cheaper alternatives, exist, they remain underused due to a lack of awareness among both doctors and patients. Despite potentially saving billions of dollars over the next decade, only a small percentage of the biologics market is made up of biosimilars. Automation, including AI-driven prescription management, is emerging as a possible solution to better inform physicians and patients about these affordable drugs and help integrate them into treatment plans.

Source: hitconsultant.net –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts